On average, women wait seven years between the onset of endometriosis symptoms and disease diagnosis—and some never receive a formal diagnosis. The chronic pain women experience plus numerous treatment failures can lead to significant physical, mental, interpersonal, and financial burdens. Join us for a roadmap to a better understanding of the diverse presentations of endometriosis and find out how you can improve your use of symptom questionnaires and other tools. What strategies can you use to successfully incorporate shared decision-making and therapy selection into your medical practice?
Individualizing Treatment Strategies for Endometriosis
Individualizing Treatment Strategies for Endometriosis
CME/CE Broadcast Replay
12
- Host: Stephen M. Cohen, MD, FACOG
- Guest: Anita L. Nelson, MD
Ensure that your management of endometriosis starts with early diagnosis and the willingness to partner with your patient to find a workable solution.
Available credits: 0.75
Time to complete: 45 minutes
Released:
Valid until:
Take Post-Test
If you’ve already completed the activity.
Disclosure of Conflicts of Interest
In accordance with the ACCME Standards for Commercial Support, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. GLC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.
Faculty:
Stephen M. Cohen, MD, FACOG
Faculty
SUNY Upstate Medical School
Syracuse, NY
Consulting Fees: AbbVieAnita L. Nelson, MD
Professor and Chair,
Department of Obstetrics and Gynecology
Western University of Health Sciences
Pomona, CA
Consulting Fees: Agile Therapeutics, AMAG, American Regent, Bayer HealthCare, Merck, Sebela Pharmaceutical, TherapeuticsMD
Commercial Interest Speakers Bureau: American Regent, Bayer HealthCare, Merck, TherapeuticsMD
Contracted Research: Agile Therapeutics, Evofem, Merck, Mithra, Sebela PharmaceuticalReviewers/Content Planners/Authors:
- Sean T. Barrett has nothing to disclose.
- Steven Chavez has nothing to disclose.
- Barry A. Fiedel, PhD, has nothing to disclose.
- Amanda Hilferty has nothing to disclose.
Learning Objectives
After participating in this educational activity, participants should be better able to:
- Identify clinical practices that lead to an accurate and timely patient-centered diagnosis of endometriosis
- Describe validated symptom assessment tools, guidelines, and expert recommendations for early intervention in clinical practice
- Employ methods and tools for endometriosis care that encourage patient participation and incorporate their preferences, goals, and values into decision-making
- Implement a personalized treatment plan for endometriosis-associated pain that considers individual clinical, biologic, and health-related quality of life measures
- Define benefits and disadvantages of various therapies for personalized treatment of endometriosis
Target Audience
This activity is designed to meet the educational needs of physicians, nurse practitioners, physician assistants, nurses, and certified nurse midwives in the fields of obstetrics and gynecology, family practice, and internal medicine.
Accreditation and Credit Designation Statements
Global Learning Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Global Learning Collaborative designates this enduring material for a maximum of .75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Provider
Omnia Education is the leading provider of education for women’s health professionals. Our activities are recognized nationwide for providing credible, relevant, and practical information on issues impacting the female patient. Additionally, our unique focus has transformed the CME learning environment, and our ability to help learners recognize and overcome barriers to optimal performance and optimal patient outcomes has positioned us as a leader in women’s health education.
Commercial Support
This activity is supported by an independent educational grant from AbbVie.
Disclaimer
he views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Omnia Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Omnia Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.
Reproduction Prohibited
Reproduction of this material is not permitted without written permission from the copyright owner.
System Requirements
Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.
Facebook Comments